Related Experiment Videos
Apoptogenesis of Immunodeficiency Diseases
Leonid V. Kovalchuk1, Anatoly N. Cheredeev
1Russian State Medical University, Moscow, Russia.
Russian Journal of Immunology : RJI : Official Journal of Russian Society of Immunology
|April 11, 2003
Summary
Enhanced apoptosis in immune cells, particularly T lymphocytes, defines apoptotic immunodeficiencies. Increased cell death may indicate disease severity, highlighting a need for antiapoptotic therapies.
Area of Science:
- Immunology
- Cell Biology
- Genetics
Background:
- Advances in immune system research reveal genetic immunodeficiency mechanisms.
- Programmed cell death (apoptosis) is crucial for T and B lymphocyte selection and immune homeostasis.
- Controlled apoptosis maintains immune system balance.
Purpose of the Study:
- To define and characterize immune deficiencies associated with excessive apoptosis.
- To identify enhanced apoptosis in lymphocytes as a marker for these conditions.
- To explore therapeutic strategies for apoptotic immunodeficiencies.
Main Methods:
- Analysis of cellular and molecular mechanisms of immune cell maturation and function.
- Investigation of programmed cell death pathways in T and B lymphocytes.
- Identification of apoptosis-triggering signals and ligands.
Main Results:
- Enhanced (pathological) apoptosis in immune cells defines apoptotic immunodeficiencies.
- Apoptosis defects, especially in T lymphocytes, are central to these conditions.
- Increased spontaneous or induced apoptosis in lymphocytes serves as a marker for apoptotic immunodeficiency.
Conclusions:
- Apoptotic immunodeficiencies result from excessive programmed cell death in the immune system.
- The degree of apoptosis can correlate with the severity of the immunodeficiency.
- Developing antiapoptotic immunocorrective drugs, potentially using cytokines, is a key goal for clinical immunology.